PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$73.69
+9.20 (+14.27%)
As of May 9, 1:16 AM ET ·
Analyst Consensus
Buy
21
Analysts
High
Coverage
Buy 14 67%
Hold 6 29%
Sell 1 5%
Price Target
Analyst Price Target +5.8% upside
Low Target $54.55
Average Target $77.98
High Target $125.35
Current Price $73.69
Current
$73.69
Target
$77.98
$54.55 $77.98 avg $125.35
Scenario Analysis
Bear Case
$54.55
-26.0%
Low target
Base Case
$77.98
+5.8%
Avg target
Bull Case
$125.35
+70.1%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$87.50
-15.8% from high
52-Week Low
$37.94
+94.2% from low
50-Day SMA
$75.08
-1.9% vs SMA
200-Day SMA
$61.55
+19.7% vs SMA
RSI (14)
25.1
Oversold
Target vs 52W High
$77.98
-10.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%